|
| Status |
Public on Dec 22, 2021 |
| Title |
Molecular signature predictive of long-term liver fibrosis progression to inform anti-fibrotic drug development |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
34951993 |
| NIH grant(s) |
| Grant ID |
Grant title |
Affiliation |
Name |
| R01 CA233794 |
Reverse-engineering precision liver cancer chemoprevention |
UT SOUTHWESTERN MEDICAL CENTER |
Yujin Hoshida |
| R01 DK099558 |
Molecular Prognostic Indicators in Liver Cirrhosis and Cancer |
MOUNT SINAI SCHOOL OF MEDICINE |
Yujin Hoshida |
|
| |
| Submission date |
Aug 12, 2016 |
| Last update date |
Apr 08, 2022 |
| Contact name |
Yujin Hoshida |
| Organization name |
University of Texas Southwestern Medical Center
|
| Street address |
5323 Harry Hines Blvd
|
| City |
Dallas |
| State/province |
TX |
| ZIP/Postal code |
75390 |
| Country |
USA |
| |
|
| Platforms (5)
|
| GPL17230 |
NanoString Prognostic Liver Signature (PLS) panel (186 genes, ver.0) |
| GPL19886 |
NanoString Prognostic Liver Signature (PLS) panel (186 genes, ver.1) |
| GPL21697 |
NextSeq 550 (Homo sapiens) |
| GPL30481 |
NanoString Prognostic Liver Signature (PLS) plus liver fibrosis panel (186-gene PLS + 24-gene extension) |
| GPL30511 |
NanoString Prognostic Liver Signature (PLS) plus ELS panel (186-gene PLS + 10-gene extension) |
|
| Samples (917)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE85546 |
Prognostic Liver Signature profiles in post-transplant liver biopsy tissues from chronic hepatitis C patients |
| GSE85547 |
Prognostic Liver Signature profiles in biopsy tissues from chronic hepatitis C patients with HIV co-infection followed for fibrosis progression |
| GSE85548 |
Prognostic Liver Signature profiles in biopsy tissues from chronic hepatitis C patients followed for fibrosis progression |
| GSE150734 |
Prognostic Liver Signature profiles in biopsy tissues from non-alcoholic fatty liver disease (NAFLD) patients in the U.S. |
| GSE161841 |
Prognostic Liver Signature profiles in biopsy tissues from non-alcoholic fatty liver disease (NAFLD) patients in Japan |
| GSE175448 |
Transcriptome profiles of liver biopsy tissues before and after cenicriviroc treatment in patients with non-alcoholic steatohepatitis |
| GSE181538 |
Expression profiling of Prognostic Liver Signature and fibrosis-related genes in clinical fibrotic liver tissue cultured with various anti-fibrotic agents |
| GSE182060 |
Prognostic liver signature profiles in biopsy tissues from non-alcoholic fatty liver disease patients followed for fibrosis progression |
| GSE182065 |
Expression profiling of prognostic liver signature in clinical fibrotic liver tissues cultured with various anti-fibrotic and chemopreventive agents |
|
| Relations |
| BioProject |
PRJNA338770 |
Less...
More...